Physician profile
Christopher A Evans
NPI 1528400272
$4,819.81
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,831 · 2022: $1,652 · 2023: $940 · 2024: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325 · Education: $10.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.22 |
| Education | $10.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,982.98 | 2021-2024 | Dovato, Cabenuva, Apretude |
| Gilead Sciences, INC. | $1,572.66 | 2021-2024 | Epclusa |
| Janssen Biotech, INC. | $443.59 | 2021-2023 | Symtuza |
| Merck Sharp & Dohme LLC | $245.79 | 2021-2023 | Pifeltro, Delstrigo |
| Janssen Products, LP | $215.89 | 2021-2022 | |
| Napo Pharmaceuticals INC | $140.94 | 2021-2022 | |
| Abbvie INC. | $133.74 | 2022-2024 | |
| Janssen Scientific Affairs, LLC | $45.00 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $39.22 | 2022-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.